During the past decade, University of Chicago Comprehensive Cancer Center conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 284 clinical trials were completed, i.e. on average, 132.1% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 94 clinical trials were completed. i.e. 188% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Chicago Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 320 trials, followed by "Alliance for Clinical Trials in Oncology" with 144 trials sponsored, "Children's Oncology Group" with 117 trials sponsored, "University of Chicago" with 74 trials sponsored and "Gynecologic Oncology Group" with 74 trials sponsored. Other sponsors include 221 different institutions and companies that sponsored additional 78 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Chicago Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 566 trials as a collaborator, "NRG Oncology" with 52 trials as a collaborator, "Cancer and Leukemia Group B" with 29 trials as a collaborator, "SWOG Cancer Research Network" with 24 trials as a collaborator and "Eastern Cooperative Oncology Group" with 22 trials as a collaborator. Other collaborators include 139 different institutions and companies that were collaborators in the rest 80 trials.

According to Clinical.Site data, the most researched conditions in "University of Chicago Comprehensive Cancer Center" are "Leukemia" (57 trials), "Lung Cancer" (49 trials), "Lymphoma" (49 trials), "Breast Cancer" (29 trials) and "Colorectal Cancer" (28 trials). Many other conditions were trialed in "University of Chicago Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Chicago Comprehensive Cancer Center" are "Drug" (775 trials), "Other" (376 trials), "Biological" (288 trials), "Procedure" (228 trials) and "Radiation" (191 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (223 trials), "Quality-of-Life Assessment" (88 trials), "radiation therapy" (73 trials), "Questionnaire Administration" (63 trials) and "Carboplatin" (57 trials). Other intervention names were less common.

The vast majority of trials in "University of Chicago Comprehensive Cancer Center" are 732 trials for "All" genders, 168 trials for "Female" genders and 48 trials for "Male" genders.

Currently, there are NaN active trials in "University of Chicago Comprehensive Cancer Center". undefined are not yet recruiting, 103 are recruiting, 210 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 524 completed trials in University of Chicago Comprehensive Cancer Center, 10 suspended trials, and 82 terminated clinical trials to date.

Out of the total trials that were conducted in University of Chicago Comprehensive Cancer Center, 129 "Phase 1" clinical trials were conducted, 507 "Phase 2" clinical trials and 281 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 29 trials that are defined as “Not Applicable".